A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Mushrooms Bookmark and Share

Mushrooms may need more might for the cancer fight

Can white button mushrooms stop prostate cancer recurrence? In a recent clinical trial at City of Hope, two patients experienced tremendous success with tablets made from concentrated white button mushrooms. Watch this story unfold.


Behold the formidable fungus.     

 

Not quite plant and not quite animal, it grows in out-of-the-way spots, avoiding attention. But if new studies at City of Hope bear fruit, the white button mushroom may enter the spotlight.

 

City of Hope scientists are on their way toward incorporating mushrooms in a cancer-fighting strategy.

 

Over the last decade, City of Hope researchers identified and tested cancer-inhibiting compounds in the common supermarket mushroom. Their work has moved into clinical trials at City of Hope, including one that tested whether consuming mushroom extract could stave off breast cancer recurrence in postmenopausal patients.

 

Early findings from that study showed that the doses of mushroom extract that were tested blocked activity of an enzyme important to breast cancer, but not at levels likely to deter the disease. The work encourages scientists to hone their potential strategy for prevention.

 

“Future studies should focus on more highly concentrated preparations of mushroom extract,” said Melanie Palomares, M.D., M.S., assistant professor of medical oncology and director of the High Risk Breast Program, who presented the results at the meeting.

 

In earlier work, Shiuan Chen, Ph.D., chair and professor of City of Hope’s Department of Cancer Biology, found that phytochemicals — naturally occurring plant chemicals — in mushrooms can block the activity of the enzyme called aromatase.

 

Aromatase helps the body produce the hormone estrogen, which many breast cancers need to grow. Blocking the enzyme chokes off the supply of estrogen to tumor cells, stunting their growth. Several drugs that block aromatase are already part of medicine’s arsenal against breast cancer.

 

Mushrooms’ natural aromatase-inhibiting properties might offer a dietary, non-drug intervention to help prevent recurrence of hormone-dependent breast cancers, according to the researchers.

 

The current study, which aimed to find an effective dose of mushroom extract, centered on postmenopausal breast cancer survivors who were cancer-free after they finished their treatment.

 

Women in the study took white button mushroom extract daily for 12 weeks. They were divided into groups that received either 5-, 8-, 10- or 13-gram doses. The researchers checked patients’ responses by measuring blood levels of estradiol, a close chemical relative of estrogen. Women whose estradiol level dropped by 50 percent or more were deemed to have responded to the intervention.

 

Patients tolerated the extract well, but the estradiol level failed to drop by 50 percent or more in any group. The researchers did see evidence of modest aromatase inhibition that lasted as long as six hours at the highest dose level. The result suggested that eating mushrooms can weakly inhibit aromatase in patients, but much higher amounts likely are necessary for a clinically significant result.

 

“Over the course of 12 weeks, we were able to observe phytochemical activity, but not at high enough concentrations to significantly reduce circulating estrogen levels in our patients,” Palomares said. In addition to trying higher concentrations of mushroom extract in future studies, the scientists also may change the way they measure estrogens in the body. “The local estrogen level in the breast is likely more significant clinically than what circulates in the bloodstream.”

 

Mushrooms

Mushrooms may need more might for the cancer fight

Can white button mushrooms stop prostate cancer recurrence? In a recent clinical trial at City of Hope, two patients experienced tremendous success with tablets made from concentrated white button mushrooms. Watch this story unfold.


Behold the formidable fungus.     

 

Not quite plant and not quite animal, it grows in out-of-the-way spots, avoiding attention. But if new studies at City of Hope bear fruit, the white button mushroom may enter the spotlight.

 

City of Hope scientists are on their way toward incorporating mushrooms in a cancer-fighting strategy.

 

Over the last decade, City of Hope researchers identified and tested cancer-inhibiting compounds in the common supermarket mushroom. Their work has moved into clinical trials at City of Hope, including one that tested whether consuming mushroom extract could stave off breast cancer recurrence in postmenopausal patients.

 

Early findings from that study showed that the doses of mushroom extract that were tested blocked activity of an enzyme important to breast cancer, but not at levels likely to deter the disease. The work encourages scientists to hone their potential strategy for prevention.

 

“Future studies should focus on more highly concentrated preparations of mushroom extract,” said Melanie Palomares, M.D., M.S., assistant professor of medical oncology and director of the High Risk Breast Program, who presented the results at the meeting.

 

In earlier work, Shiuan Chen, Ph.D., chair and professor of City of Hope’s Department of Cancer Biology, found that phytochemicals — naturally occurring plant chemicals — in mushrooms can block the activity of the enzyme called aromatase.

 

Aromatase helps the body produce the hormone estrogen, which many breast cancers need to grow. Blocking the enzyme chokes off the supply of estrogen to tumor cells, stunting their growth. Several drugs that block aromatase are already part of medicine’s arsenal against breast cancer.

 

Mushrooms’ natural aromatase-inhibiting properties might offer a dietary, non-drug intervention to help prevent recurrence of hormone-dependent breast cancers, according to the researchers.

 

The current study, which aimed to find an effective dose of mushroom extract, centered on postmenopausal breast cancer survivors who were cancer-free after they finished their treatment.

 

Women in the study took white button mushroom extract daily for 12 weeks. They were divided into groups that received either 5-, 8-, 10- or 13-gram doses. The researchers checked patients’ responses by measuring blood levels of estradiol, a close chemical relative of estrogen. Women whose estradiol level dropped by 50 percent or more were deemed to have responded to the intervention.

 

Patients tolerated the extract well, but the estradiol level failed to drop by 50 percent or more in any group. The researchers did see evidence of modest aromatase inhibition that lasted as long as six hours at the highest dose level. The result suggested that eating mushrooms can weakly inhibit aromatase in patients, but much higher amounts likely are necessary for a clinically significant result.

 

“Over the course of 12 weeks, we were able to observe phytochemical activity, but not at high enough concentrations to significantly reduce circulating estrogen levels in our patients,” Palomares said. In addition to trying higher concentrations of mushroom extract in future studies, the scientists also may change the way they measure estrogens in the body. “The local estrogen level in the breast is likely more significant clinically than what circulates in the bloodstream.”

 
City of Hope combines compassionate care with the best and most innovative science. Our 100+ acre campus is designed to meet the full range of needs of our patients and families. This guide is designed to help you take advantage of all that is offered at City of Hope - Duarte.
To make an appointment for yourself, a family member or a friend, please complete and submit our Become a Patient Request Form, or call City of Hope at
800-826-HOPE (4673).
Contact Us
Phone: (800) 826-HOPE (4673)
 
Hours: M – F, 8 a.m. to 5 p.m. (PST)
 
Calls received after 5 p.m. will be returned the next business day.
Patient Care Overview

The Sheri & Les Biller Patient and Family Resource Center embodies the heart and soul of City of Hope’s mission to care for the whole person.
Info for Referring Physicians
City of hope welcomes patient referrals from physicians throughout the world. City of Hope is located near northeast Los Angeles, in Duarte, California.

NEWS & UPDATES
  • Gliomas, a type of tumor that grows in the brain, are very difficult to treat successfully due to their complex nature. That might not always be the case. First some background: The most aggressive and common type of primary brain tumor in adults is glioblastoma. Although the brain tumor mass can often be remov...
  • Cutaneous T cell lymphomas are types of non-Hodgkin lymphoma that arise when infection-fighting white blood cells in the lymphatic system – called lymphocytes – become malignant and affect the skin. The result is rashes and, sometimes, tumors, which can be mistaken for other dermatological conditions. In a smal...
  • Weighing your breast cancer risk? One study suggests a measure to consider is skirt size. A British study suggests that for each increase in skirt size every 10 years after age 25, the five-year risk of developing breast cancer postmenopause increases from one in 61 to one in 51 – a 77 percent increase in risk....
  • Runners prize medals for 5Ks and marathons. Becky Stokes has a medal she cherishes from a very different kind of race: the marathon of treatments necessary to beat her aggressive triple-negative breast cancer. Just a week ago, she completed her last radiation treatment, and danced in the hospital with the staff...
  • Rob Darakjian was diagnosed with acute lymphoblastic leukemia at just 19 years old. He began chemotherapy and was in and out of the hospital for four months. After his fourth round of treatment, he received a bone marrow transplantation from an anonymous donor. Today, he’s cancer free. Darakjian’s s...
  • The environment plays a role in causing cancer – this much we know. But scientists are still trying to understand what that role is, what environmental factors are in play and how precisely those factors are linked to cancer. Now City of Hope researchers have unlocked a clue as to how one carcinogen triggers ca...
  • Jonathan Yamzon, M.D., assistant clinical professor of surgery in the Division of Urology and Urologic Oncology, explains his approach to what’s known as “active surveillance” of men with prostate cancer. Patients need to be educated about their treatment options, he writes. Active surveillanc...
  • For most prostate cancer patients, surgery or radiation therapy is the initial and primary treatment against the disease. But some patients can benefit from chemotherapy and hormone therapy too, especially if there are signs of a relapse or if the cancer has spread beyond the prostate gland. Here, Cy Stein, M.D...
  • Cancer research has yielded scientific breakthroughs that offer patients more options, more hope for survival and a higher quality of life than ever before. The 14.5 million cancer patients living in the United States are living proof that cancer research saves lives. Now, in addition to the clinic, hospital an...
  • Advances in cancer treatment, built on discoveries made in the laboratory then brought to the bedside, have phenomenally changed the reality of living with a cancer diagnosis. More than any other time in history, people diagnosed with cancer are more likely to survive and to enjoy a high quality of life. Howeve...
  • While health care reform has led to an increase in the number of people signing up for health insurance, many people remain uninsured or are not taking full advantage of the health benefits they now have. Still others are finding that, although their premiums are affordable, they aren’t able to see the do...
  • Kidney cancer rates and thyroid cancer rates in adults have continued to rise year after year. Now a new study has found that incidence rates for these cancers are also increasing in children — particularly in African-American children. The study, published online this month in Pediatrics, examined childhood ca...
  • Thyroid cancer has become one of the fastest-growing cancers in the United States for both men and women. The chance of being diagnosed with the cancer has nearly doubled since 1990. This year an estimated 63,000 people will be diagnosed with thyroid cancer in the United States and nearly 1,900 people will die ...
  • Older teenagers and young adults traditionally face worse outcomes than younger children when diagnosed with brain cancer and other central nervous system tumors. A first-of-its-kind study shows why. A team of researchers from the departments of Population Sciences and Pathology at City of Hope recently examine...
  • Cancer treatment can take a toll on the mouth, even if a patient’s cancer has nothing to do with the head or throat, leading to a dry mouth, or a very sore mouth, and making it difficult to swallow or eat. Here’s some advice from the National Cancer Institute (NCI)  on how to ease cancer-related dis...